Petar Ozretić

1.6k total citations
52 papers, 664 citations indexed

About

Petar Ozretić is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Petar Ozretić has authored 52 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Genetics. Recurrent topics in Petar Ozretić's work include Hedgehog Signaling Pathway Studies (20 papers), Cancer-related Molecular Pathways (11 papers) and Genomics and Chromatin Dynamics (7 papers). Petar Ozretić is often cited by papers focused on Hedgehog Signaling Pathway Studies (20 papers), Cancer-related Molecular Pathways (11 papers) and Genomics and Chromatin Dynamics (7 papers). Petar Ozretić collaborates with scholars based in Croatia, Italy and United States. Petar Ozretić's co-authors include Sonja Levanat, Maja Sabol, Vesna Musani, Lidija Beketić-Orešković, Slavko Orešković, Željko Vujašković, Božena Šarčević, Snježana Ramić, Yari Ciribilli and Držislav Kalafatić and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Petar Ozretić

48 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petar Ozretić Croatia 17 497 182 127 113 54 52 664
Lars Tögel Germany 13 381 0.8× 142 0.8× 74 0.6× 44 0.4× 67 1.2× 26 629
Katia Danza Italy 15 310 0.6× 111 0.6× 253 2.0× 121 1.1× 50 0.9× 27 529
Petra Laspe Germany 14 325 0.7× 104 0.6× 109 0.9× 41 0.4× 43 0.8× 19 564
Marialaura Petroni Italy 16 424 0.9× 198 1.1× 123 1.0× 68 0.6× 54 1.0× 25 624
Saravanan Thiyagarajan India 12 425 0.9× 216 1.2× 76 0.6× 57 0.5× 51 0.9× 25 600
Daniel H. Wiseman United Kingdom 15 529 1.1× 96 0.5× 78 0.6× 60 0.5× 37 0.7× 46 854
Gregory Khitrov United States 7 279 0.6× 72 0.4× 76 0.6× 49 0.4× 45 0.8× 10 590
Annalisa Roberti Spain 9 296 0.6× 138 0.8× 87 0.7× 33 0.3× 34 0.6× 13 505
Andy Goberdhan United States 5 346 0.7× 202 1.1× 111 0.9× 68 0.6× 58 1.1× 7 535
Shogo Shigeta Japan 15 240 0.5× 111 0.6× 130 1.0× 25 0.2× 59 1.1× 50 525

Countries citing papers authored by Petar Ozretić

Since Specialization
Citations

This map shows the geographic impact of Petar Ozretić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petar Ozretić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petar Ozretić more than expected).

Fields of papers citing papers by Petar Ozretić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petar Ozretić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petar Ozretić. The network helps show where Petar Ozretić may publish in the future.

Co-authorship network of co-authors of Petar Ozretić

This figure shows the co-authorship network connecting the top 25 collaborators of Petar Ozretić. A scholar is included among the top collaborators of Petar Ozretić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petar Ozretić. Petar Ozretić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ozretić, Petar, et al.. (2024). Clinician’s Guide to Epitranscriptomics: An Example of N1-Methyladenosine (m1A) RNA Modification and Cancer. Life. 14(10). 1230–1230. 1 indexed citations
2.
Ozretić, Petar, et al.. (2024). The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors. Cancers. 16(8). 1575–1575. 6 indexed citations
3.
Ozretić, Petar, et al.. (2024). Oral Microbiome Research in Biopsy Samples of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma and Its Challenges. Applied Sciences. 14(23). 11405–11405. 3 indexed citations
4.
Ozretić, Petar, Arjana Tambić Andrašević, Slave Trajanoski, et al.. (2024). Comparison of the Skin Microbiota in the Periocular Region between Patients with Inflammatory Skin Diseases and Healthy Participants: A Preliminary Study. Life. 14(9). 1091–1091. 1 indexed citations
5.
Ozretić, Petar, et al.. (2024). Current status of in vitro models for rare gynaecological cancer research. European Journal of Surgical Oncology. 51(4). 108549–108549.
6.
Ozretić, Petar, et al.. (2023). BIRC5 Gene Polymorphisms Are Associated with a Higher Stage of Local and Regional Disease in Oral and Oropharyngeal Squamous Cell Carcinomas. International Journal of Molecular Sciences. 24(24). 17490–17490. 3 indexed citations
7.
Lugović‐Mihić, Liborija, Petar Ozretić, Ivana Lojkić, et al.. (2023). Association of Gut Lachnospiraceae and Chronic Spontaneous Urticaria. Life. 13(6). 1280–1280. 35 indexed citations
8.
Sabol, Maja, et al.. (2023). ‘Toxic Masculinity’: What Is Known about the Role of Androgen Receptors in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 24(4). 3766–3766. 6 indexed citations
9.
Fiore, Riccardo Di, Ana Félix, Sharon O’Toole, et al.. (2021). An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma. International Journal of Molecular Sciences. 22(12). 6506–6506. 9 indexed citations
10.
Vlašić, Ignacija, et al.. (2021). Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness. Cancers. 13(20). 5231–5231. 19 indexed citations
11.
Ozretić, Petar, Maja Sabol, Vesna Musani, et al.. (2019). Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines. Scientific Reports. 9(1). 12470–12470. 18 indexed citations
12.
Linke, Matthias, Ivan Sabol, Oliver Vugrek, et al.. (2019). Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC). Translational Lung Cancer Research. 8(6). 1000–1015. 13 indexed citations
13.
Musani, Vesna, et al.. (2018). Potential hot spot for de novo mutations in PTCH1 gene in Gorlin syndrome patients: a case report of twins from Croatia. Croatian Medical Journal. 59(1). 20–24. 3 indexed citations
14.
Mršić, Gordan, et al.. (2018). Expanded Croatian 12 X-STR loci database with an overview of anomalous profiles. Forensic Science International Genetics. 34. 249–256. 11 indexed citations
15.
Ozretić, Petar, Vesna Musani, Držislav Kalafatić, et al.. (2017). Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas. International Journal of Oncology. 51(6). 1869–1877. 20 indexed citations
16.
Sabol, Maja, et al.. (2015). GSK3β and Gli3 play a role in activation of Hedgehog-Gli pathway in human colon cancer — Targeting GSK3β downregulates the signaling pathway and reduces cell proliferation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(12). 2574–2584. 44 indexed citations
17.
Sabol, Maja, Vesna Musani, Petar Ozretić, et al.. (2012). A Low-grade Ovarian Carcinoma Case With Coincident LOH of PTCH1 and BRCA1, and a Mutation in BRCA1. International Journal of Gynecological Pathology. 31(3). 264–271. 4 indexed citations
18.
Ozretić, Petar, Alessandra Bisio, Alberto Inga, & Sonja Levanat. (2012). The growing relevance of cap-independent translation initiation in cancer-related genes. Periodicum Biologorum. 114(4). 471–478. 3 indexed citations
19.
Ozretić, Petar, et al.. (2011). Tumor markers in breast cancer--evaluation of their clinical usefulness.. PubMed. 35(1). 241–7. 70 indexed citations
20.
Sabol, Maja, et al.. (2010). Epigenetic regulation of the Hedgehog-Gli signaling pathway in cancer. Institutional Repository of the Ruđer Bošković Institute (Ruđer Bošković Institute). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lars Tögel Breakdown of academic impact, for papers by Katia Danza Breakdown of academic impact, for papers by Petra Laspe Breakdown of academic impact, for papers by Marialaura Petroni Breakdown of academic impact, for papers by Saravanan Thiyagarajan Breakdown of academic impact, for papers by Daniel H. Wiseman Breakdown of academic impact, for papers by Gregory Khitrov Breakdown of academic impact, for papers by Annalisa Roberti Breakdown of academic impact, for papers by Andy Goberdhan Breakdown of academic impact, for papers by Shogo Shigeta
Rankless by CCL
2026